title: The future of red blood cell alloimmunization risk reduction.
authors.affiliation: Department of Pathology, Johns Hopkins University, Baltimore, MD.
authors.forename: Seema
authors.initials: S
authors.lastname: Kacker
authors.forename: Paul M
authors.initials: PM
authors.lastname: Ness
authors.forename: R Sue
authors.initials: RS
authors.lastname: Shirey
authors.forename: William J
authors.initials: WJ
authors.lastname: Savage
authors.forename: Karen E
authors.initials: KE
authors.lastname: King
authors.forename: Aaron A R
authors.initials: AA
authors.lastname: Tobian
mesh_terms: D000755:Anemia, Sickle Cell / Q000276:immunology* / Q000628:therapy*; D001787:Blood Group Incompatibility / Q000517:prevention & control*; D001788:Blood Grouping and Crossmatching / Q000191:economics*; D017707:Erythrocyte Transfusion / Q000009:adverse effects*; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans